Which antibiotoc is better to select empirically for lower urinary tract infections in pregnant women?
dc.contributor.author | Tosun, Migraci | |
dc.contributor.author | Ozdes, Emel Kurtoglu | |
dc.contributor.author | Yanik, Keramettin | |
dc.contributor.author | Kokcu, Arif | |
dc.contributor.author | Ozhan, Erdem | |
dc.date.accessioned | 2020-06-21T13:40:00Z | |
dc.date.available | 2020-06-21T13:40:00Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 1940-5901 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/13738 | |
dc.description | WOS: 000379157300158 | en_US |
dc.description.abstract | We evaluated the bacterial profiles and antibiotic sensitivities presenting in each trimester of pregnant women diagnosed with lower urinary tract infection. Escherichia coli was the most common isolated uropathogen (77.8%, 75%, and 52%, respectively), followed by Klebsiella pneumoniae (0%, 3.6%, and 16%, respectively), and Enterococcus faecalis (3.7%, 14.3%, and 8%, respectively). Ciprofloxacin was found to have sensitivity for all uropathogens, with 92.8% sensitivity for Escherichia coli and 100% for Klebsiella pneumoniae. Norfloxacin also exhibited high sensitivity for almost all bacterial agents, except Acinetobacter baumannii, with 91.4% sensitivity for Escherichia coli and 100% for Klebsiella pneumoniae. Phosphomycin had the highest sensitivity, 100%, for the two most common uropathogens, Escherichia coli and Klebsiella pneumoniae. Because empirical antimicrobial choices play a critical role in the prevention of unwanted complications, lower urinary tract infection in pregnancy can be treated with empirically selected phosphomycin. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | E-Century Publishing Corp | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Antibiotic sensitivity pattern | en_US |
dc.subject | empirical treatment | en_US |
dc.subject | pregnancy | en_US |
dc.subject | trimester | en_US |
dc.subject | urinary tract infection | en_US |
dc.subject | uropathogen | en_US |
dc.title | Which antibiotoc is better to select empirically for lower urinary tract infections in pregnant women? | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 9 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 12039 | en_US |
dc.identifier.endpage | 12045 | en_US |
dc.relation.journal | International Journal of Clinical and Experimental Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Scopus İndeksli Yayınlar Koleksiyonu [14046]
Scopus Indexed Publications Collection -
WoS İndeksli Yayınlar Koleksiyonu [12971]
WoS Indexed Publications Collection